V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryIn-Process Quality Gate
Quality · The complete guide

In-Process Quality Gate: Evidence and Progression Decisions

In short

Connect manufacturing evidence to a specific permission to proceed, with clear criteria, decision ownership and recovery paths.

4,108 words · ~19 min read
Operator in hood mask glasses protective clothing gloves reviewing in-process sample tray beside stopped line with tablet
In-process quality gate in an operational setting.
On this page
  1. 01What an in-process quality gate decides—and what it does not
  2. 02Regulatory basis: US drug controls and current device requirements
  3. 03Run the gate lifecycle with explicit evidence and progression states
  4. 04Connect each decision to evidence, context and authorised people
  5. 05Build decision logic from acceptance criteria, applicability and SPC
  6. 06Worked cases: pending blend approval, missing clearance and failed torque
  7. 07Configure gate scope, recipe revisions and decision ownership
  8. 08Handle late results, interface failures and controlled recovery
  9. 09Challenge the gate design before use and after changes
  10. 10Avoid controls that appear complete but permit the wrong action
  11. 11Review readiness with owners, operators and downstream users
On this page · 11 sections
  1. 1What an in-process quality gate decides—and what it does not
  2. 2Regulatory basis: US drug controls and current device requirements
  3. 3Run the gate lifecycle with explicit evidence and progression states
  4. 4Connect each decision to evidence, context and authorised people
  5. 5Build decision logic from acceptance criteria, applicability and SPC
  6. 6Worked cases: pending blend approval, missing clearance and failed torque
  7. 7Configure gate scope, recipe revisions and decision ownership
  8. 8Handle late results, interface failures and controlled recovery
  9. 9Challenge the gate design before use and after changes
  10. 10Avoid controls that appear complete but permit the wrong action
  11. 11Review readiness with owners, operators and downstream users
AI · Explain it for MY operation

How does In-Process Quality Gate apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01What an in-process quality gate decides—and what it does not

An in-process quality gate is a defined decision point during manufacturing that uses specified evidence to determine whether a batch, material or operation may proceed to a specified next step. The term describes an operational workflow model, not a legal definition. Its output is permission for a particular action, rather than simply a recorded result.

A practical gate definition brings together these components:

  • Manufacturing scope: the identified material, equipment or operation affected.
  • Evidence requirement: the observations, results or records needed for the decision.
  • Decision criteria: how that evidence supports or prevents progression.
  • Assigned authority: who is authorised to make or approve the decision.
  • Permitted next operation: the specific action that may follow.
TermQuestion answeredOperational effectBoundary
Measurement checkWhat was observed, or how does it compare?Establishes an observation or comparison.An in-process check alone does not define progression permission.
In-process quality gateMay this operation proceed?Determines progression to a specified next step.Permission applies only to the defined scope and action.
Quality holdWhich activities are restricted?Restricts activity within a defined scope.An electronic hold tag communicates a restriction, not ultimate disposition.
Final dispositionWhat is the batch or lot’s ultimate status?Determines the batch or lot’s ultimate status.A QA disposition step is distinct from intermediate progression.

A gate can govern less than the whole batch: a transfer, equipment use, assembly operation or material-consumption event. Identify the restricted action explicitly. For example, preventing transfer from a vessel does not necessarily prohibit continued mixing or sampling. Define those permissions separately so operators know what remains allowed while transfer is restricted.

02Regulatory basis: US drug controls and current device requirements

An in-process quality gate is a manufacturing control design, not a universal regulatory workflow. The binding US duties below concern human drugs and medical devices within their respective scopes. Food, supplements, chemicals and non-US manufacturing are outside this legal mapping.

Binding requirements for US human drugs

The 21 CFR 211 gate mapping for US human drugs begins with 211.110(a): established and followed written procedures describe in-process controls and tests or examinations on appropriate samples from each batch. Gate design identifies which sample record supports which intended progression decision.

For US human drugs under 21 CFR 211, 21 CFR 211.110(b) requires valid in-process specifications for the relevant characteristics to be consistent with drug product final specifications.

For US human-drug in-process material, 211.110(c) couples appropriate identity, strength, quality and purity testing with quality-control-unit approval or rejection during production. A gate evidence map distinguishes the test result from that material decision.

Where US human-drug in-process material is rejected, 211.110(d) requires identification and quarantine control preventing unsuitable manufacturing or processing use. Gate recovery practice preserves that restriction for the affected material, rather than treating a later workflow completion as clearance.

For US human drugs under 21 CFR 211, 21 CFR 211.100(a) requires written production and process-control procedures, including changes, to be drafted, reviewed and approved by appropriate organizational units, and reviewed and approved by the quality control unit.

For US human drugs under 21 CFR 211, 21 CFR 211.100(b) requires documentation at the time of performance and recording and justification of deviations from written procedures.

Current US medical-device requirements

For US medical-device manufacturers subject to 21 CFR part 820, 21 CFR 820.10(a) requires documentation of a quality management system meeting applicable ISO 13485 and part 820 requirements. See QMSR and ISO 13485 for the broader relationship; this mapping does not interpret ISO clauses.

For US medical devices under 21 CFR part 820, 21 CFR 820.3(b) defines rework as action bringing nonconforming product into conformity with specified medical-device-file requirements before it is released for distribution.

Manufacturing practice, not official guidance

The proposed gate sequence, state names, MES architecture and approval routing are implementation choices, not official guidance or universal mandates for a separate QA signature at every gate. A practical mapping connects each applicable duty to evidence, decision ownership and the operation being controlled. Maintain that mapping through change control, rather than treating a software status as the regulatory obligation itself.

03Run the gate lifecycle with explicit evidence and progression states

A practical gate lifecycle starts by binding the gate to the identified material, lot and operation. Identify the expected observations and reviews, collect evidence, evaluate it against applicable criteria, and route the evaluation to the authorised decision-maker. This is a workflow design model, not a universal software or sign-off mandate.

Evidence stateMeaningDecision consequenceRecovery route
PendingAn identified observation or review is expected but unfinished.Affected permission awaits completion.Complete the observation or review.
MissingAn expected item has no applicable record.Readiness cannot be established.Locate or obtain applicable evidence.
InvalidEvidence is unusable because its context, integrity or applicability is unsuitable.Exclude it from acceptance evaluation.Resolve suitability or obtain replacement evidence.
FailedUsable evidence does not meet its criterion.Do not permit the affected step through the normal acceptance route.Investigate and follow the defined exception route.
AcceptableUsable evidence meets its criterion.Supports, but does not itself authorise, progression.Proceed to remaining evaluation and authorisation.

Keep evidence state separate from the gate decision—awaiting authorisation, permitted or restricted—and from execution status: not started, started or completed. An evaluation can be complete while authorisation or execution remains outstanding. Execution acknowledgement records what actually occurred, not merely that permission was issued; link it through the process event log.

Make permissions operation-specific. A defined staging activity may remain available while consumption or irreversible processing is restricted, if the local procedure explicitly distinguishes those activities. Record the permitted action rather than an ambiguous overall pass.

Resolve exceptions through the assigned owner. When evidence or authority changes, create a new decision record linked to the previous one, with its reason and changed permissions; do not silently overwrite the earlier decision.

Workflow: Bind material and operation → Collect evidence → Evaluate → Authorised decision → Operation-specific permission → Execution acknowledgement. Exception → Resolve → Re-evaluate → New authorised decision.

From in-process evidence to permitted progression
  1. 1
    Bind ScopeMatch material, operation and applicable gate revision.
  2. 2
    Identify evidenceList applicable observations, criteria and responsible roles.
  3. 3
    Capture resultsRecord provenance, units, timing and material identity.
  4. 4
    Classify evidenceDistinguish pending, missing, invalid, failed and acceptable inputs.
  5. 5
    Evaluate progressionApply the defined rule to a fixed evidence snapshot.
  6. 6
    Authorise Next StepApply assigned authority; retain human quality approval.
  7. 7
    Reconcile outcomesConfirm execution or route exceptions for review.
A practice model for an operation-specific decision, not final batch disposition.

04Connect each decision to evidence, context and authorised people

A practical gate record links the source observation to its sample or inspection identity, material and operation context, applicable criterion, evaluation and authorised decision. This is a traceability design practice, not a prescribed database schema. The record should let a reviewer reconstruct why progression was permitted for the affected material at that point.

Preserve the source record identifier, result and units, evidence revision, and any correction reason. Record observed time separately from received time: an inspection may occur before its result reaches the workflow. Retaining both avoids presenting late-arriving evidence as information available when an earlier decision was made. Link corrections into the audit trail review workflow rather than replacing the original observation.

The following data-model diagram is an implementation-neutral example; arrows represent traceable references, not a required software architecture.

Source observation → sample or inspection identity → material and operation context → criterion and gate-definition revision → fixed evidence snapshot → evaluation → authorised decision and permitted next step

Context extends beyond a batch identifier. Include parent-child lot relationships through lot pedigree, the partial quantity and units covered, and the operation or equipment-use interval to which shared-equipment evidence applies. These production context links help prevent evidence for one portion or equipment use from being applied to another.

Reference a fixed evidence snapshot and gate-definition revision so the decision remains explainable against what was actually evaluated. A later result amendment creates a changed review situation; it does not rewrite the earlier decision’s basis.

Assign evidence-entry, review and progression authority by role. Distinguish a calculated evaluation from a person’s approval, recording the approver’s identity, role, time and decision scope. Keep quality approvals and final release with authorised people. This role model neither prescribes an electronic-signature system nor assumes a separate QA signature for every workflow event.

Records Behind a Traceable Gate Decision

Gate Definition

Versioned scope, criteria and authority.

  • gate_id
  • revision_id
  • operation_id
  • criteria_revision_id
  • authority_role_id

Gate Instance

The gate applied to manufacturing work.

  • gate_instance_id
  • batch_id
  • definition_revision_id
  • operation_instance_id
  • gate_state

Evidence Item

An attributable observation with applicability status.

  • evidence_id
  • source_record_id
  • sample_id
  • result_value
  • unit
  • evidence_status
  • observed_at
  • received_at

Gate Decision

Recorded authority for a specific progression.

  • decision_id
  • gate_instance_id
  • evidence_snapshot_id
  • authorised_by
  • decided_at
  • permitted_operation_id

Exception Record

Owned recovery linked to the affected gate.

  • exception_id
  • gate_instance_id
  • reason_code
  • owner_id
  • resolution_record_id
Link each decision to its scope, evidence, criteria and authorisation.

05Build decision logic from acceptance criteria, applicability and SPC

As a practical design model, permit progression only when the context matches, applicable evidence is complete and valid, acceptance criteria are satisfied, and the designated decision authority has authorised the next step. Treat these as conjunctive conditions: a satisfactory measurement cannot compensate for the wrong batch, recipe revision or sampling location. Use the evidence states described above to route pending, missing and failed evidence, rather than collapsing them into a single unsuccessful result.

Define comparison rules before evaluation: whether boundaries are inclusive, which units apply, how conversions and rounding work, and whether acceptance concerns individual samples or a specified aggregate. Separate rounding for display from the value used for comparison; a rounded screen value should not silently change the decision. For a density checkpoint, specify the measurement basis as well as the unit. Define how conflicting results are resolved, rather than selecting the favourable result or averaging away a failure.

Product or process acceptance criteria answer whether the evaluated evidence meets defined limits or conditions. Statistical process control signals answer a different question: whether observed behaviour warrants investigation for a possible process change. A trend or control-chart signal can route an otherwise acceptable result to a defined review path without being relabelled as a specification failure. Specify whether that review blocks the next step and who resolves it.

For conditional evidence, name the triggering context and the role authorised to establish applicability. Record the rule and factual basis when a check is deliberately inapplicable; an empty field is not an applicability decision. Unresolved applicability should remain visible rather than defaulting to success.

Finally, define when evidence needs reassessment. Storage, equipment intervention, material movement or a changed processing context can undermine its relevance to the intended next step. Route those events to the designated owner to assess continued validity and applicability, including whether renewed evidence is needed.

06Worked cases: pending blend approval, missing clearance and failed torque

These manufacturing-practice illustrations assume local gate rules, not industry-wide thresholds. Each gate controls a named next operation. For quality-unit authority and the device rework definition, refer to the regulatory mapping above; the examples below show how those distinctions inform progression decisions.

Drug blend: acceptable measurements, pending approval

  • Assumed scope and evidence: The gate governs progression from blending to compression. Completed identity evidence is acceptable, and the blend assay, expressed as mass fraction in g/g, falls within the local acceptance interval. The gate also assigns a quality-unit decision, which is still pending.
  • Applicable gate rule: Compression permission depends on both acceptable evidence and the assigned quality-unit approval. Acceptable measurements alone do not satisfy this assumed rule.
  • Evidence classification: Identity and assay evidence are complete and acceptable; the decision is pending. This is neither missing assay evidence nor a failed assay criterion.
  • Permitted and prohibited next actions: The assigned reviewer may examine the evidence and complete the decision. Operators may not begin compression while that decision remains pending.
  • Authorised recovery: The assigned quality-unit approver completes the review. If approval follows, a new gate decision permits compression for the identified batch. It does not constitute final batch release, and the earlier pending state remains distinguishable from the later permission.

Food filling: acceptable temperature, missing clearance

  • Assumed scope and evidence: The gate governs sauce filling on the intended line. Sauce transfer temperature, recorded in °C, meets the local criterion, but the cleaning-clearance record for that line and production context is missing.
  • Applicable gate rule: Filling permission depends on acceptable transfer temperature and applicable cleaning-clearance evidence. Neither condition substitutes for the other.
  • Evidence classification: Temperature evidence is acceptable; clearance evidence is missing. The missing record does not, by itself, establish that cleaning failed or that the line is clean.
  • Permitted and prohibited next actions: Personnel may locate or establish applicable clearance evidence and submit it for evaluation. Filling remains unavailable. A clearance for another line, or for a different production context, cannot close this evidence gap.
  • Authorised recovery: The designated clearance owner establishes the applicable record through the local procedure. The gate decision owner evaluates its relevance and acceptability before issuing a new decision. Finding an unrelated clearance does not authorise filling.

Device assembly: failed torque before closure

  • Assumed scope and evidence: The gate precedes enclosure closure. A fastening-torque result, expressed in N·m and correctly attributed to the assembly and fastening operation, lies outside the gate’s acceptance interval.
  • Applicable gate rule: Closure permission depends on acceptable fastening evidence and completion of the defined decision.
  • Evidence classification: The result is present and applicable but failed. It is not an unresolved evidence request.
  • Permitted and prohibited next actions: Personnel may preserve the result and initiate the defined nonconformance response. Enclosure closure is not permitted; repeating the measurement merely to replace the failure is not an authorised recovery.
  • Authorised recovery: The designated nonconformance owner determines the permitted response. Subsequent authorised work and new evidence support a separate evaluation, linked to the original failure and any associated deviation, rather than overwriting it.

The recovery needs differ: finish an identified decision, establish missing applicable evidence, or respond to an actual failed criterion.

07Configure gate scope, recipe revisions and decision ownership

As a recommended master-data practice, separate the reusable gate definition from each batch-specific gate instance. Document the definition in the configuration specification, with enough detail to identify exactly where permission takes effect.

  • Identity and scope: gate identifier, revision, applicable product or process family, and operation boundary.
  • Decision inputs: evidence types, criterion references and their revisions, and applicability conditions.
  • Authority and progression: decision roles and explicitly permitted successor operations.

Bind each instance to its applicable definition revision and batch context. In recipe management, publishing a newer configuration should not silently replace the definition governing work already in progress. Preserve which definition governed each decision.

Express conditional applicability using named equipment attributes, product variants and process routes. Show operators and reviewers both the condition and its consequence: for example, a gate applies only when the selected route includes a coating operation. Avoid opaque expressions that conceal why a gate applies or is omitted.

Assign owners for criteria, role assignments and successor-operation mappings. Review the physical consequence of each routing permission—such as transfer into another vessel—not merely whether the form can be completed.

After a change, deliberately retain the applicable revision for in-flight batches or perform an authorised transition. Record the rationale and impact assessment, including how existing evidence and decisions remain applicable and whether any newly permitted operation changes the batch’s handling.

08Handle late results, interface failures and controlled recovery

Integration is a design option, not a prerequisite for a quality gate. As implementation-neutral practice, interfaces can connect execution records, laboratory results, equipment observations and inventory status while preserving each source’s identity. Define which source owns each fact and how updates reach the gate; MES–historian integration is one possible connection, not an assumed product capability.

Correlate evidence using source record identity, sample or inspection identity, material scope, operation and evidence revision. A matching product name alone does not establish applicability to the material awaiting progression. Route ambiguous matches to an exception queue with an assigned owner rather than attaching them by guesswork.

Use idempotent processing: receiving the same message again should not create another decision or repeat an action. Evaluate amendments by revision, not arrival order, so an older result cannot overwrite its replacement. Preserve superseded evidence. Send unresolved revision conflicts to the owned exception queue; assess late results against affected decisions and any progression already recorded.

Record permission separately from confirmation that the downstream action occurred. After a timeout, reconcile acknowledgements, execution records and physical state before retrying. For example, an absent transfer acknowledgement does not establish that no material moved. Blind repetition could duplicate an irreversible operation; unresolved execution status belongs with the recovery owner.

Define a controlled offline or paper fallback that captures source identity and actual event time, consistent with contemporaneous recording. Retain the same restricted-action rules during the outage. When connectivity returns, reconcile fallback and electronic records, distinguish event time from entry time, and reassess affected decisions before further dependent actions. Assign responsibility for closing discrepancies rather than treating restored connectivity as completed recovery.

09Challenge the gate design before use and after changes

Use risk-based validation to challenge decision behaviour and physical consequences, not just successful data entry. The following is a recommended practice approach.

  • Present a valid result attributed to the wrong material or lot; confirm that it cannot satisfy the intended gate.
  • Submit incompatible units and values below, at and above an acceptance boundary. Check unit handling and inclusive or exclusive boundary interpretation.
  • Use stale evidence, attempt a decision with an unauthorised role, and change evidence after a decision. Check the resulting permissions and decision history.
  • Test every defined evidence state against each permitted next action, explicitly distinguishing pending, missing and failed evidence. Where the process separates operational staging from material consumption, test both actions independently.
  • Interrupt transactions, repeat messages and recover after an unacknowledged downstream action. Apply the recovery design above and observe whether the physical action occurred, rather than relying only on screen status.

Retain expected outcomes, observed outcomes and traceable decision records through requirements traceability. Include an operator walk-through: identify ambiguous prompts, ask what action the operator would take, and confirm who owns each exception.

For changes, assess affected gate definitions, active instances, evidence mappings and successor operations. Make regression testing proportionate to affected decision paths, including shared rules. Record the rationale for retesting or excluding each path and the treatment of decisions already made.

10Avoid controls that appear complete but permit the wrong action

These practice-based safeguards address designs that look complete while allowing an unjustified next step.

  • Convenient sample substitution: record explicit sample-to-scope applicability before using a result. For example, connect the sample to the relevant cavity through mold cavity tracking, rather than accepting any result from the batch.
  • Skipped check treated as passed: use a separate applicability outcome with its rationale; a check judged inapplicable has not demonstrated acceptance.
  • Undocumented supervisor bypass: replace an unrestricted override button with a controlled exception decision identifying the named authority, reason, affected scope and reviewable decision history.
  • Success indicator without actionable meaning: display the permitted operation, decision basis and remaining restrictions, rather than leaving operators to interpret a green status.
  • Incentives focused on gate closure: use management review to examine exception quality and inappropriate progression, not just completion speed. Assess whether decisions resolved the evidence issue rather than merely cleared the queue.

11Review readiness with owners, operators and downstream users

Use this practical cross-functional checklist before putting a gate into operation:

  • Identify the exact restricted action.
  • Confirm who owns each evidence item.
  • Approve criterion applicability for the intended scope.
  • Assign decision authority.
  • Identify owners for exceptions.
  • Agree recovery arrangements and responsibility for resuming work.
  • Confirm downstream acknowledgement of the decision and permitted action.

At the point of work, ask operators to explain what they can do now, what they cannot do and what would change that answer. Ask reviewers to reconstruct a decision from its recorded scope and evidence in the batch execution history.

Using the opening comparison, confirm that operational progression remains separate from final disposition. Use the FAQs to apply this model to specific edge cases, rather than repeating the regulatory mapping or state table.

Frequently asked questions

Q.Can material move to a non-consuming staging step while a laboratory result is still pending?+

As a workflow-design practice, staging can be permitted when the procedure explicitly separates relocation from permission to consume material. Define the destination, segregation, storage conditions, tracking and prohibited subsequent operations. A pending result means testing remains unresolved; missing evidence means the decision record is incomplete; failed evidence needs a different assessment. Use a controlled quarantine location where appropriate, and keep material consumption blocked under the procedure until the designated decision-maker authorizes progression. Staging permission does not establish material acceptability.

Q.Does every in-process gate need a separate quality-unit signature?+

No; the regulatory section sets out the 21 CFR 211.110(c) quality-unit duty and the signature caveat. When several gates close at once, record each decision against its own scope and evidence rather than one combined approval. In practice, distinguish that material decision from routine operator verification. Define who records observations, who evaluates exceptions and who authorizes each next step; use a QA disposition step where that decision belongs rather than duplicating signatures without a distinct purpose.

Q.How should a gate handle split lots or equipment shared by several batches?+

In practice, attach each progression decision to its actual scope: identified material portions, equipment, processing interval and relevant evidence. For split lots, distinguish evidence applicable to the parent from checks specific to each child; do not inherit approval merely because the parent passed. Bin-level lot genealogy helps define those relationships. For shared equipment, use production context tagging to connect observations to affected batches. Assess a common equipment problem across potentially affected material rather than restricting review to whichever batch first revealed it.

Q.What changes when an out-of-limit result is corrected as a transcription error?+

Treat the correction as a change to the decision evidence, not permission to erase the original failure. A practical procedure preserves the original entry, identifies the authoritative measurement, records the correction and rationale, and assigns review authority. Then reassess the gate using the corrected evidence and check whether any intervening action depended on the erroneous value. Audit trail review can support that assessment. If the underlying measurement was actually out of limit, correcting its transcription does not resolve the measurement problem.

Q.Can an SPC warning restrict progression when all acceptance results are satisfactory?+

Yes, as a defined process-control practice. A gate can evaluate both acceptance results and a separate statistical warning condition. Apply the SPC-versus-acceptance distinction set out under decision logic, and state whether the response is investigation, additional observation or restricted progression. Explain which signal triggered the restriction and who can remove it. A statistical process control warning may indicate changing process behavior without establishing product nonconformance; satisfactory acceptance results do not, by themselves, resolve a separately defined warning condition.

Q.Which gate revision applies when a recipe changes while a batch is already running?+

Use an explicit transition decision rather than silently applying the newest revision. In practice, change control should identify affected running batches, the effective operation and whether earlier evidence remains applicable. Record the selected gate and recipe revision together, including any reassessment needed before continuation. For a partly completed batch, list which operations already ran under the earlier revision and which gates the remaining steps will use; master-data setup explains the transition principles.

Q.How can a paper-based operation use quality gates without an MES?+

A practical paper gate uses a controlled batch record entry tied to a named operation step. Include the material identity, evidence references, decision criteria, unresolved items, authorized next action, decision-maker and decision time. Pair the record with physical status identification and a handoff that receiving personnel check before proceeding. Define how corrections and changes reach every affected station. The control depends on disciplined execution and reconciliation of copies, not on having an electronic screen or a software-enforced block.

Q.What should downstream users do when evidence supporting an earlier progression decision is invalidated?+

A practical response starts by identifying which decisions depended on that evidence and preventing further affected progression while designated personnel assess the consequences. Use batch execution history to locate material already transferred, consumed or transformed, and notify the responsible downstream users. Preserve the earlier decision as a historical event, but mark its supporting evidence as invalidated and record the reassessment. Replacement evidence should be evaluated for applicability before a new authorization; it should not silently overwrite the basis of earlier actions.

Primary sources

  • 21 CFR 211.110
  • 21 CFR 211.100
  • 21 CFR 820.10
  • 21 CFR 820.3
Software that covers In-Process Quality Gate
V5 Ultimate Medical Device MES
Device history records built from signed steps at the workstation: component lots, configured step order, inspections, UDI and…
V5 Ultimate (21 CFR Part 11)
V5 Ultimate gives FDA-regulated manufacturers bound e-signatures, an audit trail, authority checks and printed-copy controls. An…
V5 Ultimate (QMSR)
The FDA Quality Management System Regulation (QMSR) — the harmonized replacement for 21 CFR 820 — became effective 2 February…
V5 Ultimate ISO 13485 QMS
Design controls with a live requirements-trace matrix, ISO 14971 risk file linked to software requirements per IEC 62304, CAPA /…
Talk to us about In-Process Quality Gate

Want to see how In-Process Quality Gate could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Where this term comes up
PharmaceuticalMedical DevicesDietary SupplementsFood ProcessingCosmeticsChemicals
Inside V5
  • → eBMR / eDHR — the batch record fills in as the work is done.
  • → 21 CFR Part 11 — signatures and audit history your team can validate.
Example reports
V5Ultimate

Sample report

Electronic Batch Manufacturing Record (eBMR)

Plan & make

Electronic Batch Manufacturing Record (eBMR)View on screen or print
V5Ultimate

Sample report

Electronic Device History Record (eDHR)

Plan & make

Electronic Device History Record (eDHR)View on screen or print
V5Ultimate

Sample report

Compliance Readiness Assessment

Quality system

Compliance Readiness AssessmentView on screen or print
V5Ultimate

Sample report

Validation Support Pack

Quality system

Validation Support PackView on screen or print
→ All example reports
Regulatory anchors
  • 21 CFR 211.110
  • ISO 13485:2016 cl. 8.2.6 via 21 CFR 820.10 (QMSR; replaced former 820.80)
  • 21 CFR Part 11
  • ISA-95
Related terms
  • → MES
  • → SPC
  • → CPV
  • → Line Clearance
  • → E-Signature
  • → In-Process Reconciliation

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC